RecruitingNot applicableNCT05340868

Genetics of the Acute Response to Oral Semaglutide

Studying Genetic obesity

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medical University of Bialystok
Principal Investigator
Lukasz Szczerbinski, MD, PhD
Clinical Research Centre, Medical University of Bialystok
Intervention
Semaglutide Pill(drug)
Enrollment
1000 target
Eligibility
18-65 years · All sexes
Timeline
20222025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05340868 on ClinicalTrials.gov

Other trials for Genetic obesity

Additional recruiting or active studies for the same condition.

See all trials for Genetic obesity

← Back to all trials